MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,718,000 | +34.2% | 128,001 | +2.3% | 0.10% | +25.3% |
| Q1 2016 | $5,753,000 | -13.6% | 125,114 | -9.2% | 0.08% | -2.5% |
| Q4 2015 | $6,660,000 | +20.2% | 137,782 | +5.7% | 0.08% | +3.8% |
| Q3 2015 | $5,541,000 | -27.8% | 130,380 | +94.1% | 0.08% | -26.4% |
| Q2 2015 | $7,671,000 | -11.4% | 67,168 | +0.1% | 0.11% | +3.9% |
| Q1 2015 | $8,660,000 | +56.4% | 67,093 | +20.7% | 0.10% | +59.4% |
| Q4 2014 | $5,537,000 | +31.9% | 55,589 | +30.9% | 0.06% | +14.3% |
| Q3 2014 | $4,198,000 | +9.2% | 42,462 | -14.8% | 0.06% | +12.0% |
| Q2 2014 | $3,843,000 | -2.9% | 49,859 | -18.9% | 0.05% | 0.0% |
| Q1 2014 | $3,959,000 | +73.8% | 61,501 | +72.3% | 0.05% | +47.1% |
| Q4 2013 | $2,278,000 | +32.8% | 35,690 | +24.7% | 0.03% | -17.1% |
| Q3 2013 | $1,715,000 | +112.8% | 28,618 | +74.7% | 0.04% | +156.2% |
| Q2 2013 | $806,000 | – | 16,381 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |